Owen Hughes's Insider Trades & SAST Disclosures
Owen Hughes's most recent trade in XOMA Corp was a trade of 53,360 Common Stock done . Disclosure was reported to the exchange on Nov. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Owen Hughes.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 53,360 | 56,860 (0%) | 0% | 0 | Common Stock | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 53,360 | 221,640 | - | - | Performance Stock Units | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 11 Nov 2024 | 21,881 | 34,979 (0%) | 0% | 30.0 | 655,336 | Common Stock |
| C4 Therapeutics Inc | Owen P. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Ikena Oncology Inc | Owen P. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 17,520 | 17,520 | - | - | Stock Option (Right to Buy) | |
| XOMA Corp | Owen P. Hughes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 275,000 | 275,000 | - | - | Performance Stock Units | |
| Ikena Oncology Inc | Owen Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 17,520 | 17,520 | - | - | Stock Option (Right to Buy) | |
| XOMA Corp | Owen Hughes | Director, Interim CEO | Purchase of securities on an exchange or from another person at price $ 23.79 per share. | 23 May 2023 | 1,032 | 2,000 (0%) | 0% | 23.8 | 24,551 | Depositary Shares - 8.375% B Cumulative Stock |
| XOMA Corp | Owen Hughes | Director, Interim CEO | Purchase of securities on an exchange or from another person at price $ 23.49 per share. | 23 May 2023 | 768 | 968 (0%) | 0% | 23.5 | 18,040 | Depositary Shares - 8.375% B Cumulative Stock |
| XOMA Corp | Owen Hughes | Director, Interim CEO | Purchase of securities on an exchange or from another person at price $ 23.33 per share. | 23 May 2023 | 200 | 200 (0%) | 0% | 23.3 | 4,666 | Depositary Shares - 8.375% B Cumulative Stock |
| XOMA Corp | Owen Hughes | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| XOMA Corp | Owen Hughes | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Ikena Oncology Inc | Owen Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 35,040 | 35,040 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Owen Hughes | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 12 Jan 2021 | 2,500 | 506,226 | - | 21 | 52,500 | Common Stock |
| Cullinan Oncology Inc | Owen Hughes | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 433,332 | 433,332 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges